The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?
1 Department of Radiation Oncology, Centre Georges François Leclerc, University of Burgundy, Dijon, France ; 2 Medical imaging group, IMAC CNRS 6306, University of Burgundy, Esplanade Erasme, Dijon, France ; 3 Department of Medical Oncology, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519 Vandoeuvre-lès-Nancy, France ; 4 EA 4360, Lorraine University, 9 Avenue de la Forêt de Haye, 54505 Vandœuvre-lès-Nancy, France.
Gilles
G
Créhange
1 Department of Radiation Oncology, Centre Georges François Leclerc, University of Burgundy, Dijon, France ; 2 Medical imaging group, IMAC CNRS 6306, University of Burgundy, Esplanade Erasme, Dijon, France ; 3 Department of Medical Oncology, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519 Vandoeuvre-lès-Nancy, France ; 4 EA 4360, Lorraine University, 9 Avenue de la Forêt de Haye, 54505 Vandœuvre-lès-Nancy, France.
Thierry
T
Conroy